留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

聚合物胶束作为药物载体及其在肿瘤靶向方面的研究进展

吴韫韬 张依依

吴韫韬, 张依依. 聚合物胶束作为药物载体及其在肿瘤靶向方面的研究进展[J]. 药学实践与服务, 2013, 31(2): 86-89,115. doi: 10.3969/j.issn.1006-0111.2013.02.002
引用本文: 吴韫韬, 张依依. 聚合物胶束作为药物载体及其在肿瘤靶向方面的研究进展[J]. 药学实践与服务, 2013, 31(2): 86-89,115. doi: 10.3969/j.issn.1006-0111.2013.02.002
WU Yun-tao, ZHANG Yi-yi. Advances in polymeric micelles for drug delivery and tumor targeting[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(2): 86-89,115. doi: 10.3969/j.issn.1006-0111.2013.02.002
Citation: WU Yun-tao, ZHANG Yi-yi. Advances in polymeric micelles for drug delivery and tumor targeting[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(2): 86-89,115. doi: 10.3969/j.issn.1006-0111.2013.02.002

聚合物胶束作为药物载体及其在肿瘤靶向方面的研究进展

doi: 10.3969/j.issn.1006-0111.2013.02.002

Advances in polymeric micelles for drug delivery and tumor targeting

  • 摘要: 聚合物胶束具有粒径小、稳定性高、滞留时间长、良好的生物相容性等特点,这些优良性质使得聚合物胶束作为药物载体具有许多独特的优势。近年来,涌现了许多围绕聚合物胶束设计肿瘤靶向给药系统的报道,包括利用肿瘤的病理学性质,设计被动靶向给药系统和对聚合物胶束进行表面修饰,设计主动靶向给药系统。本文主要综述了聚合物胶束作为肿瘤靶向药物载体的研究进展。
  • [1] Wang L, Zeng R, Li C, et al. Self-assembled polypeptide-block-poly (vinylpyrrolidone) as prospective drug-delivery systems[J]. Colloids and Surfaces B:Biointerfaces, 2009, 74:284.
    [2] Yokoyama M, Okano T, Sakurai Y, et al. Introduction of cisplatin into polymeric micelles[J]. J Control Release, 1996, 39:351.
    [3] Shen Y, Jiasheng T. Synthesis and characterization of low molecular weight hyaluronic acid-based cationic micelles for efficient siRNA delivery[J]. Carbohydrate Polym, 2009, 77:95.
    [4] Rijcken CJ, Snel CJ, Schiffelers RM, et al. Hydrolysable core-crosslinked thermosensitive polymeric micelles:synthesis, characterisation and in vivo studies[J]. Biomaterials, 2007, 28:5581.
    [5] Otsuka H, Nagasaki Y, Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications[J]. Adv Drug Deliv Rev, 2003, 55:403.
    [6] Lipinski CA, Lombardo F, Dominy BW, et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings[J]. Adv Drug Deliv Rev, 2001, 46:3.
    [7] Zhang Z, Grijpma DW, Feijen J. Thermo-sensitive transition of monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) films to micellar-like nanoparticles[J]. J Control Release, 2006, 112:57.
    [8] Li Y, Kwon GS. Methotrexate esters of poly(ethyleneoxide)-blockpoly(2-hydroxyethyl-L-aspartamide). I Effects of the level of methotrexate conjugation on the stability of micelles and on drug release[J]. Pharm Res, 2000, 17:607.
    [9] Kozlov MY, Melik-Nubarov NS, Batrakova EV, et al. Relationship between Pluronic block copolymer structure, critical micellization concentration and partitioning coefficients of low molecular mass solutes[J]. Macromolecules, 2000, 33:3305.
    [10] Lavasanifar A, Samuel J, Kwon GS. The effect of alkyl core structure on micellar properties of poly(ethylene oxide)-block-poly(Laspartamide) derivatives[J]. Colloids Surfaces B Biointerfaces, 2001, 22:115.
    [11] Lee ES, Na K, Bae YH. Polymeric micelles for tumor pH and folate mediated targeting[J]. J Control Release, 2003, 91:103.
    [12] Lee ES, Na K, Bae YH, et al. Poly(l-histidine)-PEG block copolymer micelles and pH-induced destabilization[J]. J Control Release, 2003, 90:363.
    [13] Rejinold NS, Muthunarayanan M, Divyarani VV, et al. Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery[J]. J Colloid Interface Sci, 2011, 360:39.
    [14] Rejinold NS, Sreerekha PR, Chennazhi KP, et al. Biocompatible, biodegradable and thermo-sensitive chitosan-g-poly (N-isopropylacrylamide) nanocarrier for curcumin drug delivery[J]. Int J Biol Macromol, 2011, 49:161.
    [15] Kim JH, Emoto K, Iijima M, et al. Core-stabilized polymeric micelle as potential drug carrier:increased solubilization of taxol[J]. Polym Adv Technol, 1999, 10:647.
    [16] Butsele KV, Sibreta P, Fustin CA, et al. Synthesis and pH-dependent micellization of diblock copolymer mixtures[J]. J Colloid Interf Sci, 2009, 329:235.
    [17] Patil YB, Toti US, Khdair A, et al. Single-step surface functionalization of polymeric nanoparticles for targeted drug delivery[J]. Biomaterials, 2009, 30:859.
    [18] Taillefer J, Jones MC, Brasseur N, et al. Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs[J]. J Pharm Sci, 2000, 89:52.
    [19] Der ZL, Jui HH, Xian CF, et al. Synthesis, characterization and drug delivery behaviors of new PCP polymeric micelles[J]. Carbohydrate Polym, 2007, 68:544.
    [20] Adams ML, Lavasanifar A, Kwon GS. Amphiphilic block copolymers for drug delivery[J]. J Pharm Sci, 2003, 92:1343.
    [21] Yunhai L, Xiaohong C, Mingbiao L, et al. Selfassembled micellar nanoparticles of a novel star copolymer for thermo and pH dual-responsive drug release[J]. J Colloid Interf Sci, 2009, 329:244.
    [22] Wilhelm M, Zhao CL, Wang YC, et al. Poly(styrene-ethylene oxide) block copolymer micelle formation in water:a fluorescence probe study[J]. Macromolecules, 1991, 24:1033.
    [23] Chen Y, Sone M, Fuchise K, et al. Structural effect of a series of block copolymers consisting of poly(Nisopropylacrylamide and poly(N-hydroxyethylacrylamide) on thermoresponsiv behavior[J]. React Funct Polym, 2009, 69:463.
    [24] Cho YW, Lee J, Lee SC, et al. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles[J]. J Control Release, 2004, 97:249.
    [25] Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature, the key role of tumor selective macromolecular drug targeting[J]. Adv Enzyme Regul, 2001, 41:189.
    [26] Acharya S, Sahoo SK. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect[J]. Adv Drug Deliv Rev, 2011, 63:170.
    [27] Torchillin VP, Iakaubov LZ, Estrov Z. Therapeutic potential of antinuclear autoantibodies in cancer[J]. Cancer Ther, 2003, 1:179.
    [28] Knock E, Deng L, Krupenko N, et al. Susceptibility to intestinal tumorigenesis in folate-deficient mice may be influenced by variation in one-carbon metabolism and DNA repair[J]. J Nutr Biochem, 2011, 22:1022.
    [29] Hageluken A, Grunbaum L, Numberg B, et al. Lipophilic beta-adrenoceptor antagonist and local anaesthetics are effective direct activators of G-proteins[J]. Biochem Pharmacol, 1994, 47:1789.
    [30] Dharap SS, Qiu B, Williams GC, et al. Molecular targeting of drug delivery systems to ovarian cancers by BH3 and LHRH peptides[J]. J Control Release, 2003, 91:61.
    [31] Lee AL, Yong W, Cheng HY, et al. The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles[J]. Biomaterials, 2009, 30:919.
    [32] Rijcken CJ, Snel CJ, Schiffelers RM, et al. Hydrolysable core-crosslinked thermosensitive polymeric micelles:synthesis, characterisation and in vivo studies[J]. Biomaterials, 2007, 28:5581.
    [33] Mannaris C, Averkiou MA. Investigation of microbubble response to long pulses used in ultrasound-enhanced drug delivery[J]. Ultrasound Med Biol, 2012, 38:681.
    [34] Wei A, Zhou D, Ruan J, et al. Anti-tumor and anti-angiogenic effects of Macrothelypteris viridifrons and its constituents by HPLC-DAD/MS analysis[J]. J Ethnopharmacol, 2012, 139:373.
  • [1] 卞康晴, 郭灵怡, 迟文雅, 俞媛.  聚合物囊泡的稳定性及H+透膜特性考察 . 药学实践与服务, 2024, 42(1): 12-17. doi: 10.12206/j.issn.2097-2024.202309010
    [2] 韩凌, 孙治国, 鲁莹.  抗肿瘤药物纳米粒载体的制备材料、包载药物及修饰方法 . 药学实践与服务, 2018, 36(4): 307-312,350. doi: 10.3969/j.issn.1006-0111.2018.04.005
    [3] 刘丹, 张军东, 廉云飞, 房秋雨, 李娟.  核-壳结构的脂质-聚合物杂化纳米粒的研究进展 . 药学实践与服务, 2018, 36(1): 13-17. doi: 10.3969/j.issn.1006-0111.2018.01.003
    [4] 刘曼, 刘丽云, 孙凡, 林厚文.  靶向肺癌干细胞的海绵抗肿瘤活性化合物的发现 . 药学实践与服务, 2017, 35(4): 304-307. doi: 10.3969/j.issn.1006-0111.2017.04.005
    [5] 蒋琦, 钱其军.  化疗药物靶向肿瘤相关免疫抑制性细胞的研究进展 . 药学实践与服务, 2015, 33(2): 163-166,182. doi: 10.3969/j.issn.1006-0111.2015.02.019
    [6] 高洪元, 吴建勇, 倪曙民.  双级靶向纳米载体在脑肿瘤诊断和治疗方面的应用 . 药学实践与服务, 2015, 33(1): 9-12,16. doi: 10.3969/j.issn.1006-0111.2015.01.003
    [7] 解方园, 俞媛, 耿雯倩, 钟延强.  双配体修饰聚合物泡囊的制备及细胞摄取 . 药学实践与服务, 2015, 33(1): 44-48. doi: 10.3969/j.issn.1006-0111.2015.01.011
    [8] 李文清, 邹豪, 钟延强.  肿瘤靶向纳米递释系统存在问题的分析 . 药学实践与服务, 2015, 33(2): 106-109,170. doi: 10.3969/j.issn.1006-0111.2015.02.003
    [9] 孟慧, 毛峻琴, 刘昌胜, 魏杰.  介孔分子筛在医药领域中的应用 . 药学实践与服务, 2012, 30(4): 262-265.
    [10] 王晓宇, 高静, 张玮, 朱全刚, 武鑫, 高申.  细胞外激活纳米载药系统研究进展 . 药学实践与服务, 2012, 30(1): 4-7,57. doi: 10.3969/j.issn.1006-0111.2012.01.002
    [11] 陈婷, 鲁莹.  载抗肿瘤药物纳米靶向给药系统的研究进展 . 药学实践与服务, 2011, 29(3): 176-178,196.
    [12] 侯雪梅, 崔黎丽, 李国栋, 李卫华.  抗肿瘤药物靶向制剂研究进展 . 药学实践与服务, 2007, (5): 273-275,280.
    [13] 傅应华.  国内微球剂的最新研究进展 . 药学实践与服务, 2001, (5): 284-286.
    [14] 陈建明, 张仰眉, 高申.  受脂质体作为药物载体的研究进展 . 药学实践与服务, 2001, (4): 214-218.
    [15] 张立超, 胡晋红.  聚合物水分散体包衣技术的进展 . 药学实践与服务, 1999, (3): 144-148.
    [16] 孙华君, 朱全刚, 胡晋红.  脂质体经皮给药研究进展 . 药学实践与服务, 1999, (4): 221-224.
    [17] 郭涛.  释放肽和蛋白质的聚合物 . 药学实践与服务, 1995, (2): 86-86.
    [18] 郭建平.  用水分散性胶体共聚物制药物微囊 . 药学实践与服务, 1995, (2): 102-103.
    [19] 陈士景, 汤森节, 周全.  喷雾干燥的微型包囊工艺和不同聚合物包料对其的影响 . 药学实践与服务, 1993, (2): 131-133.
    [20] 李力节, 周全.  以聚乙二醇与吐温—80的混合物作固体分散体的载体提高难溶性药物的溶解 . 药学实践与服务, 1991, (3): 59-60.
  • 加载中
计量
  • 文章访问数:  2251
  • HTML全文浏览量:  237
  • PDF下载量:  499
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-05-05
  • 修回日期:  2012-10-09

聚合物胶束作为药物载体及其在肿瘤靶向方面的研究进展

doi: 10.3969/j.issn.1006-0111.2013.02.002

摘要: 聚合物胶束具有粒径小、稳定性高、滞留时间长、良好的生物相容性等特点,这些优良性质使得聚合物胶束作为药物载体具有许多独特的优势。近年来,涌现了许多围绕聚合物胶束设计肿瘤靶向给药系统的报道,包括利用肿瘤的病理学性质,设计被动靶向给药系统和对聚合物胶束进行表面修饰,设计主动靶向给药系统。本文主要综述了聚合物胶束作为肿瘤靶向药物载体的研究进展。

English Abstract

吴韫韬, 张依依. 聚合物胶束作为药物载体及其在肿瘤靶向方面的研究进展[J]. 药学实践与服务, 2013, 31(2): 86-89,115. doi: 10.3969/j.issn.1006-0111.2013.02.002
引用本文: 吴韫韬, 张依依. 聚合物胶束作为药物载体及其在肿瘤靶向方面的研究进展[J]. 药学实践与服务, 2013, 31(2): 86-89,115. doi: 10.3969/j.issn.1006-0111.2013.02.002
WU Yun-tao, ZHANG Yi-yi. Advances in polymeric micelles for drug delivery and tumor targeting[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(2): 86-89,115. doi: 10.3969/j.issn.1006-0111.2013.02.002
Citation: WU Yun-tao, ZHANG Yi-yi. Advances in polymeric micelles for drug delivery and tumor targeting[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(2): 86-89,115. doi: 10.3969/j.issn.1006-0111.2013.02.002
参考文献 (34)

目录

    /

    返回文章
    返回